Clinical trials
Observational Hyperparathyroidism, Secondary trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2016 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie (prior sponsor, Abbott) | 1 |
| Columbia University | 1 |
| National Center for Research Resources (NCRR) | 1 |
| Saint Louis VA Medical Center | 1 |
| Thomas Nickolas | 1 |
| Washington University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperparathyroidism, Secondary | 6 |
| Renal Insufficiency, Chronic | 3 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 2 |
| Kidney Failure, Chronic | 2 |
| Bone Diseases, Metabolic | 1 |
| Fractures, Bone | 1 |
| Hyperparathyroidism, Primary | 1 |
| Parathyroid Neoplasms | 1 |
| Vitamin D Deficiency | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.